Steve Meyers has over 20 years of commercial experience that includes several buy and bill, specialty pharmacy and innovative technology product launches in highly competitive markets. Prior to joining Ocular Therapeutix in 2022, Mr. Meyers has served in other commercial capacities at leading biotechnology organizations including Regeneron, AbbVie, and Procter & Gamble. Most recently, Mr. Meyers served as Vice President Sales at Flexion Therapeutics in the orthopedic space. Mr. Meyers holds a B.S. from Louisiana State University in Cardio-Pulmonary Science.